| Lisha Ryanne Porch-petitt, CNS | |
|
2000 S Wheeling Ave, Ste 200, Tulsa, OK 74104-5649 | |
| (918) 748-7854 | |
| (918) 293-3116 |
| Full Name | Lisha Ryanne Porch-petitt |
|---|---|
| Gender | Female |
| Speciality | Certified Clinical Nurse Specialist (cns) |
| Experience | 16 Years |
| Location | 2000 S Wheeling Ave, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104054147 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364S00000X | Clinical Nurse Specialist | 0058269 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tulsa Spine & Specialty Hospital | Tulsa, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ahs Oklahoma Physician Group Llc | 9436122496 | 298 |
News Archive
CANCER RESEARCH Danish researchers have just presented a previously unknown mechanism that inhibits the ability of cells to develop into cancer cells. Their findings have important implications for the understanding of how cancer starts, and how to improve the treatment of illness in the future.
People infected with COVID-19 experience a wide range of symptoms and severities, the most commonly reported including high fevers and respiratory problems.
A study by a leading Alzheimer's researcher at the University of Kentucky provides new evidence that will help researchers home in on the molecular mechanisms involved in inflammation of the central nervous system (CNS) and aid drug-development strategies for treating inflammatory neurological diseases.
The number of people who died as a result of Hurricane Maria - which hit Puerto Rico on September 20, 2017 - may be as high as 1,139, surpassing the official death count of 64, according to researchers.
Pluristem Therapeutics Inc. today announced that safety and potential efficacy parameters were demonstrated by the three month follow up data from the first patient ever to receive its placenta derived cell therapy product, PLX-PAD. The patient is participating in a Phase I dose-escalating clinical trial in Europe with PLX-PAD, the company's leading product candidate for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD).
› Verified 4 days ago
| Entity Name | Ahs Oklahoma Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235182775 PECOS PAC ID: 9436122496 Enrollment ID: O20040817001197 |
News Archive
CANCER RESEARCH Danish researchers have just presented a previously unknown mechanism that inhibits the ability of cells to develop into cancer cells. Their findings have important implications for the understanding of how cancer starts, and how to improve the treatment of illness in the future.
People infected with COVID-19 experience a wide range of symptoms and severities, the most commonly reported including high fevers and respiratory problems.
A study by a leading Alzheimer's researcher at the University of Kentucky provides new evidence that will help researchers home in on the molecular mechanisms involved in inflammation of the central nervous system (CNS) and aid drug-development strategies for treating inflammatory neurological diseases.
The number of people who died as a result of Hurricane Maria - which hit Puerto Rico on September 20, 2017 - may be as high as 1,139, surpassing the official death count of 64, according to researchers.
Pluristem Therapeutics Inc. today announced that safety and potential efficacy parameters were demonstrated by the three month follow up data from the first patient ever to receive its placenta derived cell therapy product, PLX-PAD. The patient is participating in a Phase I dose-escalating clinical trial in Europe with PLX-PAD, the company's leading product candidate for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD).
› Verified 4 days ago
| Entity Name | Pain Management Of Tulsa P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932240041 PECOS PAC ID: 0244335131 Enrollment ID: O20070423000135 |
News Archive
CANCER RESEARCH Danish researchers have just presented a previously unknown mechanism that inhibits the ability of cells to develop into cancer cells. Their findings have important implications for the understanding of how cancer starts, and how to improve the treatment of illness in the future.
People infected with COVID-19 experience a wide range of symptoms and severities, the most commonly reported including high fevers and respiratory problems.
A study by a leading Alzheimer's researcher at the University of Kentucky provides new evidence that will help researchers home in on the molecular mechanisms involved in inflammation of the central nervous system (CNS) and aid drug-development strategies for treating inflammatory neurological diseases.
The number of people who died as a result of Hurricane Maria - which hit Puerto Rico on September 20, 2017 - may be as high as 1,139, surpassing the official death count of 64, according to researchers.
Pluristem Therapeutics Inc. today announced that safety and potential efficacy parameters were demonstrated by the three month follow up data from the first patient ever to receive its placenta derived cell therapy product, PLX-PAD. The patient is participating in a Phase I dose-escalating clinical trial in Europe with PLX-PAD, the company's leading product candidate for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisha Ryanne Porch-petitt, CNS 1515 N Harvard Ave, Ste E, Tulsa, OK 74115-4957 Ph: (918) 832-6049 | Lisha Ryanne Porch-petitt, CNS 2000 S Wheeling Ave, Ste 200, Tulsa, OK 74104-5649 Ph: (918) 748-7854 |
News Archive
CANCER RESEARCH Danish researchers have just presented a previously unknown mechanism that inhibits the ability of cells to develop into cancer cells. Their findings have important implications for the understanding of how cancer starts, and how to improve the treatment of illness in the future.
People infected with COVID-19 experience a wide range of symptoms and severities, the most commonly reported including high fevers and respiratory problems.
A study by a leading Alzheimer's researcher at the University of Kentucky provides new evidence that will help researchers home in on the molecular mechanisms involved in inflammation of the central nervous system (CNS) and aid drug-development strategies for treating inflammatory neurological diseases.
The number of people who died as a result of Hurricane Maria - which hit Puerto Rico on September 20, 2017 - may be as high as 1,139, surpassing the official death count of 64, according to researchers.
Pluristem Therapeutics Inc. today announced that safety and potential efficacy parameters were demonstrated by the three month follow up data from the first patient ever to receive its placenta derived cell therapy product, PLX-PAD. The patient is participating in a Phase I dose-escalating clinical trial in Europe with PLX-PAD, the company's leading product candidate for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD).
› Verified 4 days ago
Teressa Headrick Lemaster, CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1705 E 19th St, Suite 302, Tulsa, OK 74104 Phone: 918-748-7585 Fax: 918-748-7539 | |
Lisa Darcell Davis, APRN-CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 6161 S Yale Ave, Suite A100, Tulsa, OK 74136 Phone: 918-494-8500 Fax: 918-307-5578 | |
Suzanne Kirby, Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave Ste 1105, Tulsa, OK 74104 Phone: 918-579-5749 | |
Kristin Mariah Pruitt, APRN-CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1265 S Utica Ave, Suite 300, Tulsa, OK 74104 Phone: 918-592-0999 Fax: 918-592-1021 | |
Ruth Ann Fritz, CNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 6465 S Yale Ave Ste 401, Tulsa, OK 74136 Phone: 918-561-6141 Fax: 918-582-3593 | |
Tammy Irene Joplin, APRN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1923 S Utica Ave, Tulsa, OK 74104 Phone: 918-744-2769 | |
Julia Anne Jackson, APRN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1422 E 71st St Ste B, Tulsa, OK 74136 Phone: 918-710-0422 Fax: 918-949-6681 |